Lyka Labs Ltd.

BSE: 500259 | NSE: LYKALABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE933A01014 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Lyka Labs Ltd. Lyka Labs Ltd. | BSE 88.06 -0.48 (-0.54%) | NSE 87.93 -0.96 (-1.08%) | Trade | Add

BSE Live

Nov 14, 16:01

88.06 -0.48 (-0.54%)

Volume

AVERAGE VOLUME

5-Day

4,930

10-Day

2,782

30-Day

1,556

2,272

NSE Live

Nov 14, 15:43

87.93 -0.96 (-1.08%)

Volume

AVERAGE VOLUME

5-Day

34,877

10-Day

21,916

30-Day

21,378

24,691

Financials

Print/Copy to Excel : Go

Profit & Loss account of Lyka Labs (in Rs. Cr.)	Sep 09
	18 mths
INCOME
Revenue From Operations [Gross]	175.78
Less: Excise/Sevice Tax/Other Levies	10.35
Revenue From Operations [Net]	165.43
Total Operating Revenues	165.43
Other Income	5.92
Total Revenue	171.38
EXPENSES
Cost Of Materials Consumed	84.65
Purchase Of Stock-In Trade	30.81
Operating And Direct Expenses	3.25
Changes In Inventories Of FGWIP And Stock In Trade	2.23
Employee Benefit Expenses	14.02
Finance Costs	11.81
Depreciation And Amortisation Expenses	4.74
Other Expenses	21.43
Total Expenses	174.87
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-3.49
Exceptional Items	0.00
Profit/Loss Before Tax	-3.49
Tax Expenses-Continued Operations
Current Tax	0.00
Less: MAT Credit Entitlement	0.00
Deferred Tax	0.00
Other Direct Taxes	0.13
Total Tax Expenses	0.13
Profit/Loss After Tax And Before ExtraOrdinary Items	-3.62
Profit/Loss From Continuing Operations	-4.02
Profit/Loss For The Period	-4.02
Minority Interest	0.84
Consolidated Profit/Loss After MI And Associates	-4.86
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	-2.00
Diluted EPS (Rs.)	-2.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00
Tax On Dividend	0.00